ST2 and mortality in non–ST-segment elevation acute coronary syndrome
American Heart Journal, 2010ST2 is a member of the interleukin-1 receptor family that is up-regulated in conditions associated with increased myocardial strain. ST2 has been shown to be independently predictive of adverse outcome in heart failure and ST-segment elevation myocardial infarction, but its prognostic value in non-ST-elevation acute coronary syndrome (NSTE-ACS) has not
Eggers, KM +6 more
openaire +3 more sources
Non-ST Segment Elevation Acute Coronary Syndromes: A Comprehensive Review
Southern Medical Journal, 2006As the non-ST segment elevation acute coronary syndromes (NSTEACS) include unstable angina pectoris (UAP) and the non-ST segment elevation myocardial infarction (NSTEMI), acute diagnosis and risk stratification can often prove challenging. This review will cover guidelines and strategies for risk assessment, contemporary approaches to acute patient ...
Abelardo, Martinez-Rumayor +1 more
openaire +2 more sources
Anticoagulation in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome
Journal of Pharmacy Practice, 2010There are currently over 1 million patients admitted to hospitals in the United States with the diagnosis of non-ST-segment elevation acute coronary syndrome (NSTE ACS). Due to the significant morbidity and mortality associated with NSTE ACS, appropriate use of the numerous medications employed is critical in ensuring optimal outcomes.
Paul P, Dobesh, Toby C, Trujillo
openaire +2 more sources
Speckle Tracking Echocardiography in Non–ST-Segment Elevation Acute Coronary Syndromes
Current Problems in Cardiology, 2021Non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) are a group of clinical conditions characterized by acute myocardial ischemia. Conventional echocardiography is generally used to evaluate cardiac function using wall motion analysis and left ventricular ejection fraction but may be insufficient to explore all the complex features of NSTE ...
D, Mele +7 more
openaire +2 more sources
Non–ST-Segment Elevation Acute Coronary Syndrome
AACN Advanced Critical Care, 2011Of the nearly 1.4 million hospitalizations for acute coronary syndromes in 2006, approximately two-thirds were for unstable angina (UA) or non–ST-segment elevation myocardial infarction (NSTEMI). Given the high risk for in-hospital ischemic events and late mortality in patients with UA/NSTEMI, it is critical to accurately and rapidly diagnose these ...
openaire +1 more source
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
JAMA, 2004Acute coronary syndromes are a frequent cause of hospital admission for patients with coronary artery disease. The pathophysiology of acute coronary syndromes often involves plaque rupture or fissure with platelet aggregation. Recognition of the importance of platelet aggregation resulted in several large randomized trials testing 3 types of platelet ...
openaire +2 more sources
Pathogenesis and Early Management of Non–ST-segment Elevation Acute Coronary Syndromes
Cardiology Clinics, 2006NSTE ACS is a clinically significant problem. Endothelial dysfunction triggered by traditional cardiovascular risk factors (and perhaps by other as yet unidentified risks) in the susceptible host leads to the formation and development of atherosclerotic plaque.
Tomas H, Ayala, Steven P, Schulman
openaire +2 more sources
Managing patients with non-ST-segment elevation acute coronary syndrome
Nursing Standard, 2006Acute coronary syndromes (ACSs) can be described as ST-segment elevation or non-ST-segment elevation, including unstable angina. Traditionally, ST-segment elevation ACS has been considered to be more serious, but non-ST-segment elevation ACS has higher mortality rates in the longer term.
openaire +2 more sources
Transfusion practice and outcomes in non–ST-segment elevation acute coronary syndromes
American Heart Journal, 2008To describe the association between transfusion and outcomes as a function of nadir hematocrit (HCT) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS).The adverse outcomes associated with transfusion in NSTE ACS is uncertain and may vary by nadir HCT of the transfused.Using data from 44242 patients with NSTE ACS in 400 US ...
Karen P, Alexander +10 more
openaire +2 more sources
Cardiogenic Shock Complicating Non-ST-Segment Elevation Acute Coronary Syndrome
2002Classically, cardiogenic shock has been considered a sequela of ST-segment elevation myocardial infarction, most commonly caused by left ventricular dysfunction resulting from ongoing ischemia and cell necrosis. In keeping with this scenario, most of the current literature on cardiogenic shock confines itself to ST-segment elevation.
David R. Holmes, David Hasdai
openaire +1 more source

